QCB Faculty Dr. Steve Kay Received a New R01

QCB faculty Dr. Steve Kay received a new R01 from the National Cancer Institute entitled "Discovery of novel small molecules targeting a circadian regulatory complex for cancer therapeutics”. The grant supports a suite of high-throughput assays Dr. Kay’s lab has developed to identify small molecule ligands for the core clock proteins CRY1, BMAL1, and CLOCK.